Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry tracks Stent-Graft safety in thousands of patients

NCT ID NCT04907240

Ongoing Knowledge-focused Sponsor: W.L.Gore & Associates Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is tracking over 600 people who received the GORE VIABAHN stent-graft as part of their normal medical care for conditions like peripheral artery disease or aneurysms. Researchers are monitoring how often serious device-related problems occur. The goal is to see how safe the device is in real-world use, outside of controlled clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX) (a stent-graft device)
What this could lead to
If successful, this registry will confirm the device's safety in everyday use, supporting its continued use for various vascular conditions.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove the device works better than alternatives. Results depend on routine care and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMODIALYSIS ACCESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Accidental Injuries injury peripheral arterial disease Popliteal Artery Aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMODIALYSIS ACCESS PERIPHERAL ARTERY DISEASE POPLITEAL ANEURYSM TRAUMA INJURY VISCERAL ARTERY ANEURYSMS

Contacts and locations

Locations

  • Alvaro Cunqueiro Hospital

    Vigo, 36213, Spain

  • Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona

    Ancona, 60127, Italy

  • Cardioangiologisches Centrum Bethanien

    Frankfurt, 60389, Germany

  • Centre Hospitalier Regional Universitaire de Brest

    Brest, 29200, France

  • Centre Hospitalier Unversitaire d'Angers

    Angers, 49933, France

  • Clinique RHENA

    Strasbourg, 67000, France

  • Dipartimento di Scienze Chirurgiche e Morfologiche

    Varese, 21100, Italy

  • Fondazione Poliambulanza

    Brescia, 25124, Italy

  • Greater Glasgow Health Board

    Glasgow, G12 0XH, United Kingdom

  • Hopital Edouard Herriot (HCL)

    Lyon, 69002, France

  • Hospital Paris Saint-Joseph

    Paris, 75014, France

  • Hospital Universitari Germans Trias i Pujol

    Barcelona, 08916, Spain

  • Karolinska University Hospital

    Solna, 171 64, Sweden

  • Krankenhaus Reinbek St. Adolf-Stift

    Reinbek, 21465, Germany

  • Marien Krankenhaus

    Hamburg, 22087, Germany

  • Medical Center Leeuwarden

    Leeuwarden, 8934 AD, Netherlands

  • Ospedale San Giovanni Molinette

    Torino, 10126, Italy

  • Papageorgiou Hospital

    Pávlos, 564 29, Greece

  • Queen Elizabeth Hospital

    London, SE18 4QH, United Kingdom

  • Rijnstate

    Arnhem, 6800 TA, Netherlands

  • S.C. Chirurgia Vascolare dell'A.O.U. di Modena

    Modena, 41124, Italy

  • Skane University Hospital

    Malmö, SE-205 02, Sweden

  • Southmead Hospital

    Bristol, BS10 5NB, United Kingdom

  • University Hospital Tuebingen

    Tübingen, 72076, Germany

  • University of Heidelberg

    Heidelberg, D-69120, Germany

  • iD3 Medical cvba

    Sint-Agatha-Berchem, 1082, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.